1,151
Participants
Start Date
July 23, 2018
Primary Completion Date
November 17, 2023
Study Completion Date
February 16, 2024
Fenofibrate 145 mg
One tablet (taken daily with normal renal function, taken every second day with chronic kidney disease)
Placebo Oral Tablet
One tablet (taken daily with normal renal function, taken every second day with chronic kidney disease)
NHS Grampian, Aberdeen
NHS Lanarkshire, Airdrie
NHS Ayrshire and Arran, Ayr
NHS Dumfries and Galloway, Dumfries
NHS Tayside, Dundee
NHS Fife, Dunfermline
NHS Lanarkshire, East Kilbride
NHS Lothian, Edinburgh
NHS Greater Glasgow and Clyde, Glasgow
NHS Highland, Inverness
NHS Ayrshire and Arran, Kilmarnock
NHS Fife, Kirkcaldy
NHS Forth Valley, Larbert
NHS Borders, Melrose
NHS Tayside, Perth
NHS Lanarkshire, Wishaw
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Glasgow
OTHER
University of Aberdeen
OTHER
University of Dundee
OTHER
University of Edinburgh
OTHER
NHS Scotland Diabetic Retinopathy Screening Collaborative
OTHER
University of Oxford
OTHER